These findings bring together cycad-associated ALS-PDC with colon, liver, and prostate cancer; they also add to evidence linking changes in microRNA status both to ALS, AD, and parkinsonism and to cancer initiation and progression. This evidence concerns the gene PDC and amyotrophic lateral sclerosis.